Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer.
Saved in:
| Title: | Mitomycin C + high-dose medroxyprogesterone versus cyclophosphamide+doxorubicin plus fluorouracil as first-line treatment for metastatic breast cancer. |
|---|---|
| Authors: | Falkson CI; Department of Medical Oncology, University of Pretoria, South Africa., Falkson G, Falkson CB, Falkson HC |
| Source: | Oncology [Oncology] 1992; Vol. 49 (6), pp. 418-21. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
